UBS Maintains a 'Neutral' on Cepheid (CPHD); Solid Top-Line Eclipsed by Below-Consensus EPS
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on Cepheid (NASDAQ: CPHD) price target lowered from $45 to $44.
Analyst Daniel Arias, "In our view, 1Q highlights the highs & lows of a rapid business expansion. While CPHD remains on track to grow sales 20+% in ’12 & ‘13 via aggressive menu expansion & increased geographic reach, the risks associated with managing expenses have clearly increased. Going fwd, margins will be negatively impacted in 2Q, but mgmt stated that issues are quickly being dealt with, and is committed to cost control in ’12. We look for 2H margin recovery, but are c.autious on R&D expenses in light of multiple regulatory submissions over the next 24 months."
"For ’12-’13 we maintain our estimates of $340m & $413m, respectively, & now project EPS of $0.16 (was $0.20) & $0.46 (was $0.49) – on lower GMs & higher op expenses."
For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.
Shares of Cepheid closed at $40.58 yesterday.
Analyst Daniel Arias, "In our view, 1Q highlights the highs & lows of a rapid business expansion. While CPHD remains on track to grow sales 20+% in ’12 & ‘13 via aggressive menu expansion & increased geographic reach, the risks associated with managing expenses have clearly increased. Going fwd, margins will be negatively impacted in 2Q, but mgmt stated that issues are quickly being dealt with, and is committed to cost control in ’12. We look for 2H margin recovery, but are c.autious on R&D expenses in light of multiple regulatory submissions over the next 24 months."
"For ’12-’13 we maintain our estimates of $340m & $413m, respectively, & now project EPS of $0.16 (was $0.20) & $0.46 (was $0.49) – on lower GMs & higher op expenses."
For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.
Shares of Cepheid closed at $40.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
